Diagnosis and Treatment of Metabolic Acidosis in Patients with Chronic Kidney Disease – Position Statement of the Working Group of the Polish Society of Nephrology

Abstract

Metabolic acidosis is commonly found in patients with chronic kidney disease (CKD), and its causes are: impaired ammonia excretion, reduced tubular bicarbonate reabsorption and insufficient renal bicarbonate production in relation to the amount of acids synthesised by the body and ingested with food. As the consequence, numerous metabolic abnormalities develop, which may lead to dysfunction of several organs. In observational studies, it has been found that CKD patients with metabolic acidosis are characterised by faster progression of kidney disease towards end stage kidney failure, and by increased mortality. Results of interventional studies suggest that alkali therapy in CKD patients slows progression of kidney disease. In view of these facts, the members of “The Working Group of the Polish Society of Nephrology on Metabolic and Endocrine Abnormalities in Kidney Diseases” have prepared the following statement and guidelines for the diagnosis and treatment of metabolic acidosis in CKD patients. Measurement of bicarbonate concentration in venous plasma or venous blood to check for metabolic acidosis should be performed in all CKD patients and metabolic acidosis in these patients should be diagnosed when the venous plasma or venous blood bicarbonate concentration is lower than 22 mmol/l. In patients with metabolic acidosis and CKD, oral sodium bicarbonate administration is recommended. The goal of such a treatment is to achieve a plasma or blood bicarbonate concentration equal to or greater than 22 mmol/l.

Is Metabolic Acidosis a Novel Risk Factor for a Long-Term Graft Survival in Patients after Kidney Transplantation?

“…A similar relationship was also shown in stage 3 CKD patients with serum bicarbonate concentration <23 mmol/L [15]. Based on results from the above-mentioned studies, the Working Group of the Polish Society of Nephrology suggests in their guidelines a correction of MA in this group of patients [16].…”

Contribuição da dieta e água alcalina na redução de complicações da doença renal crônica

“…Junto aos pulmões, os rins são responsáveis pela manutenção do pH do líquido extracelular dentro de valores muito estreitos, corroborando para homeostase do corpo humano 16,19,20 .…”

Accepting a chronic kidney disease patient for perioperative management: a narrative review of key aspects

“…The pH < 7.35 is rare and treatment with sodium bicarbonate generally maintains the homeostasis when the serum bicarbonate concentration falls below 20-23 mmol/L. 20 Gastrointestinal System: The gastric and small intestinal epithelial tight junctions get disrupted in CKD. 21 Erosive gastritis and duodenitis are common, 22 leading to anorexia, nausea, vomiting, gastrointestinal bleeding, diarrhea, delayed gastric emptying time, increased acidity and gastric volume necessitate the use of H 2 blockers and proton pump inhibitors.…”